FlexTrade First Provider to Offer Goldman Sachs Order Status Updates via API
3.4.2025 12:02:00 CEST | Business Wire | Press release
Goldman Sachs collaborates with FlexTrade to improve real-time data delivery to the buy-side
FlexTrade Systems (@FlexTrade), a global leader in multi-asset execution and order management systems, has today announced that Goldman Sachs' real-time Order Status Updates (OSUs) for algorithmic orders can be streamed directly into FlexTrade’s OEMS Order Blotter via a new proprietary API – fundamentally changing how Goldman Sachs delivers data to buy-side clients.
The announcement is part of Goldman Sachs’ new suite of real-time alerting and data analytics offering, GS Alerts, which is aimed at providing clients with seamless access to metrics from within their EMS/OMS blotter. The new OSUs package offers metrics for orders in developed and emerging markets in EMEA equities, including expected residuals, estimated quantity reserved for the close, and the average participation rate of the order.
Using a new API to deliver OSU data, rather than FIX, opens new possibilities regarding the frequency and type of data being delivered to FlexTrade clients, eliminating unnecessary overheads caused by additional message traffic. FlexTrade normalizes the delivery mechanism, ensuring a seamless experience for existing OSU users, while providing flexibility for the sell-side.
Alex Harman, Managing Director at Goldman Sachs, noted: “We are thrilled our OSUs are now available via FlexTrade. This is set to fundamentally change how we deliver data to the buy-side, providing clients with greater transparency and oversight of their orders. Until now, Order Status Updates have been delivered by the market in unstandardised formats and channels, presenting delivery challenges and impacting the buy-side's experience consuming data. We have therefore opted to deliver OSUs via an API, increasing the breadth of data available to clients via a scalable and robust protocol.”
The new OSU analytics offering is directly integrated within FlexTrade’s OEMS Order Blotter, replacing the need to receive updates via additional screens or chat tools. Clients can organize their visible metrics to meet their unique trading requirements, as the complete data set is available in the FlexTrade blotter within specified standard columns – eliminating the need to request these metrics on a periodic basis. Additionally, the OSU data can be combined with FlexTrade’s alerting mechanisms and the FlexAlgoWheel framework, similar to traditional order status data. For example, if a trader has an expected residual, they can cancel or replace orders or build dynamic automation rules to increase their participation rate via FlexAlgoWheel.
Andy Mahoney, Managing Director, EMEA at FlexTrade Systems, stated: “Our clients include some of the largest, most complex financial institutions globally who regularly handle vast numbers of orders and executions. Adding any data, no matter how valuable to the end user, on top of a critical trading protocol has always been unnecessarily burdensome, which has stifled innovation. With API delivery of OSUs, it’s now possible for clients to receive a broadened range of analytics at an increased frequency, without adding message traffic or protocol overheads. Now, they can efficiently receive a comprehensive data set which improves transparency, helps adjust trading styles, and contributes to better decision-making.”
About FlexTrade
FlexTrade Systems is a provider of customized multi-asset execution and order management trading solutions for buy- and sell-side financial institutions. Through deep client partnerships with some of the world's largest, most complex and demanding capital markets firms, we develop the flexible tools, technology, and innovation that deliver our clients a competitive edge. Our globally distributed engineering teams focus on adaptable technology and open architecture to develop highly sophisticated trading solutions that can automate and scale with your business strategies.
About Goldman Sachs
Goldman Sachs is a leading global financial institution that delivers a broad range of financial services to a large and diversified client base that includes corporations, financial institutions, governments and individuals. Founded in 1869, the firm is headquartered in New York and maintains offices in all major financial centers around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250403735038/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom